XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE PREFERRED STOCK, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS EQUITY - USD ($)
$ in Thousands
Redeemable convertible preferred stock
Preferred Stock
Redeemable preferred stock
Preferred Stock
Common Stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Adoption of new accounting standard
Accumulated deficit
Adoption of new accounting standard
Total
Beginning balance, preferred stock at Dec. 31, 2020 $ 154,800 $ 10,735              
Beginning balance, preferred stock (in shares) at Dec. 31, 2020 209,529,798 3,500              
Beginning balance at Dec. 31, 2020     $ 486 $ 79,706 $ 4,174   $ (60,067)   $ 24,299
Beginning balance (in shares) at Dec. 31, 2020     48,608,176            
Reverse Recapitalization transaction $ (154,800)   $ 2,498 189,056         191,554
Reverse Recapitalization transaction (in shares) (209,529,798)   249,792,546            
PIPE financing     $ 300 279,885         280,185
PIPE financing (in shares)     30,000,000            
Redemption of Redeemable Preferred Stock   $ (10,735)   (29,069)         (29,069)
Redemption of Redeemable Preferred Stock (in shares)   (3,500)              
Exercise of options     $ 104 17,566         17,670
Exercise of options (in shares)     10,388,231            
Stock-based compensation       23,763         23,763
Deferred consideration related to acquisition of Optile     $ 2 (2)          
Deferred consideration related to acquisition of Optile (in shares)     218,798            
Other comprehensive income (loss), net of tax         (1,393)       (1,393)
Net income (loss)             (15,085)   (15,085)
Ending balance at Sep. 30, 2021     $ 3,390 560,905 2,781   (75,152)   491,924
Ending balance (in shares) at Sep. 30, 2021     339,007,751            
Beginning balance at Jun. 30, 2021     $ 3,384 550,952 3,436   (75,989)   481,783
Beginning balance (in shares) at Jun. 30, 2021     338,351,977            
Exercise of options     $ 4 1,320         1,324
Exercise of options (in shares)     436,976            
Stock-based compensation       8,635         8,635
Deferred consideration related to acquisition of Optile     $ 2 (2)          
Deferred consideration related to acquisition of Optile (in shares)     218,798            
Other comprehensive income (loss), net of tax         (655)       (655)
Net income (loss)             837   837
Ending balance at Sep. 30, 2021     $ 3,390 560,905 2,781   (75,152)   491,924
Ending balance (in shares) at Sep. 30, 2021     339,007,751            
Beginning balance at Dec. 31, 2021     $ 3,404 575,470 2,253 $ (2,505) (94,054) $ (2,505) 487,073
Beginning balance (in shares) at Dec. 31, 2021     340,384,157            
Issuance of shares in connection with stock-based compensation plan     $ 98 15,185         15,283
Issuance of shares in connection with stock-based compensation plan (in shares)     9,809,530            
Stock-based compensation       39,132         39,132
Other comprehensive income (loss), net of tax         (4,516)       (4,516)
Net income (loss)             (1,819)   (1,819)
Ending balance at Sep. 30, 2022     $ 3,502 629,787 (2,263)   (98,378)   532,648
Ending balance (in shares) at Sep. 30, 2022     350,193,687            
Beginning balance at Jun. 30, 2022     $ 3,464 611,997 (605)   (71,926)   542,930
Beginning balance (in shares) at Jun. 30, 2022     346,439,294            
Exercise of options     $ 38 3,935         3,973
Issuance of shares in connection with stock-based compensation plan (in shares)     3,754,393            
Stock-based compensation       13,855         13,855
Other comprehensive income (loss), net of tax         (1,658)       (1,658)
Net income (loss)             (26,452)   (26,452)
Ending balance at Sep. 30, 2022     $ 3,502 $ 629,787 $ (2,263)   $ (98,378)   $ 532,648
Ending balance (in shares) at Sep. 30, 2022     350,193,687